Latest Breaking News On - Minor species - Page 9 : comparemela.com

Thursday, February 4, 2021 Market research shows that more than half of US households keep pets, and this number is likely to increase as people continue to be isolated, stay at home, or seek the mental and physical benefits associated with pet ownership during the COVID-19 outbreak.  With ownership comes responsibility for the welfare of pets; however, healthcare can be only as good as the available diagnostic tools and treatments.  Beyond routine checkups, preventative medicine, and the diagnosis and treatment of common diseases in animals, veterinary medicine often uses drugs and devices to diagnose and treat rare diseases. Through the Minor Use/Major Species (MUMS) pathway, the U.S. Food and Drug Administration (FDA), recently granted conditional approval to Anivive Lifesciences Inc. for verdinexor (Laverdia-CA1) tablets as a treatment for canine lymphoma, a disease that affects fewer than 70,000 dogs in the U.S. each year.  Similar to the FDA’s Orphan Products

Anivive lifesciences incProducts developmentDrug administrationMajor speciesAnivive lifesciencesOrphan products developmentMinor speciesப்ராடக்ட்ஸ் வளர்ச்சிமுக்கிய இனங்கள்ஆர்ஃபந் ப்ராடக்ட்ஸ் வளர்ச்சிமைனர் இனங்கள்